Duke Immunology sponsors a guest lecturer seminar series at 11:30 am every Tuesday during the academic year in the Edwin L. Jones Building, room 143. The program enjoys annual sponsorship from Biolegend, Inc.. Twice a year the Departments of Molecular Genetics and Microbiology and Immunology host joint speakers to facilitate collaboration between the two programs.
Duke Immunology also runs a trainee seminar series known as Works in Progress (WIP) that meets Monday from 4:00-5:00 pm during the academic year in the Medical Science Research Building, room 001.
Remembering D. Bernard Amos
The capstone seminar each year is the D. Bernard Amos Research Lecture supported by the D. Bernard Amos Fellowship Endowment. The lecture was established by the Department of Immunology to honor his memory and recognize his many contributions to medical research, education and service. A poster competition provides trainees with the opportunity to showcase their work and win awards. This event is facilitated by a student committee. Students and postdocs are invited to all speaker lunches as a networking opportunity after each seminar. Seminar refreshments are provided.
D. Bernard Amos Research Bernard was born April 16, 1923 in Bromley, Kent, England. He completed his medical training at Guy’s Hospital in London and began his research career there as a fellow in 1952. In 1962, he was recruited to Duke University as Professor of Immunology and Professor of Experimental Surgery to establish the Division of Immunology. As Chief of the Division of Immunology (1962-1993), he built one of the premier clinical and research transplantation centers in the world. After a long and successful career, Bernard retired as James B. Duke Professor of Immunology and Experimental Surgery in 1993.
Bernard made seminal and enduring scientific contributions to the areas of immunogenetics, tumor immunity and transplantation immunology. His efforts to move laboratory findings to the bedside are some of the best examples of translational science culminating directly in the improved treatment of human disease.